MagForce AG Stock price Xetra

Equities

MF6

DE000A0HGQF5

Biotechnology & Medical Research

End-of-day quote Xetra 06:00:00 2022-08-10 pm EDT 5-day change 1st Jan Change
0.1165 EUR -.--% Intraday chart for MagForce AG -.--% -.--%
Sales 2020 1.5M 1.62M Sales 2021 1.08M 1.16M Capitalization 61.3K 66.16K
Net income 2020 14M 15.11M Net income 2021 -10M -10.79M EV / Sales 2020 * -
Net cash position 2020 * - 0 Net cash position 2021 * - 0 EV / Sales 2021 * -
P/E ratio 2020 *
-
P/E ratio 2021 *
-
Employees 33
Yield 2020 *
-
Yield 2021 *
-
Free-Float 74.32%
More Fundamentals * Assessed data
Dynamic Chart
3 years
0.11
Extreme 0.11
4.56
5 years
0.11
Extreme 0.11
5.72
10 years
0.11
Extreme 0.11
8.90
More quotes
Managers TitleAgeSince
Chief Executive Officer 84 13-08-31
Director of Finance/CFO 52 12-05-02
Members of the board TitleAgeSince
Chairman 52 21-08-11
Director/Board Member 43 -
Director/Board Member - -
More insiders
Magforce AG is a Germany-based company engaged in the provision of nanotechnology solutions for health sector. Its non-invasive technology uses magnetic nanoparticles to combat tumors, without harmful effect on the healthy tissues. The Company's range of treatment products includes NanoTherm Therapie for treating tumors locally; NanoTherm, a fluid containing ferrous oxide molecules that penetrate deeply into the tumor tissues and reacting to the presence of a magnetic field; NanoActivator, which are iron oxide nanoparticles for tumors in all areas of the body, and NanoPlan, a software platform that facilitates therapy planning and adjusts proper temperatures for the treatment and and the necessary magnetic field strength. As of December 31, 2011, Nanostart AG held a 49.6%-stake in the Company.
More about the company

Chiffre d''affaires - Rate of surprise

  1. Stock
  2. Equities
  3. Stock MagForce AG
  4. Stock MagForce AG - Xetra